Other Species / Isoforms
  NuaK1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S22-p
LGLGAPGsPREAVAG
0 6
NuaK1 (human) LGLGAPGsPREAVAG S22-p
NuaK1 (mouse) VETGLPGSPLEAVAG S22
NuaK1 (rat) VETGLPGSPREVVAG S22
S85
GRVVAIKSIRKDKIK
0 1
NuaK1 (human) GRVVAIKSIRKDKIK S85
NuaK1 (mouse) GRVVAIKsIRKDKIK S86-p
NuaK1 (rat) GRVVAIKSIRKDKIK S86
Y141-p
YASKGELyDYIsERR
0 2
NuaK1 (human) YASKGELyDYIsERR Y141-p
NuaK1 (mouse) YASKGELyDYIsERR Y142-p
NuaK1 (rat) YASKGELYDYISERR Y142
S145-p
GELyDYIsERRRLSE
0 2
NuaK1 (human) GELyDYIsERRRLSE S145-p
NuaK1 (mouse) GELyDYIsERRRLSE S146-p
NuaK1 (rat) GELYDYISERRRLSE S146
T211-p
QKDKFLQtFCGSPLY
Upstream
Downstream
5 2
Effects on Modified Protein
  • enzymatic activity, induced
Effects on Biological Processes:
  • cell cycle regulation
  • cell growth, altered
  • cell growth, inhibited
Kinase, in vitro:
  • LKB1 (human)
Phosphatases, in vitro:
  • PPP1CB (human)
Putative in vivo kinases:
  • LKB1 (human)
  • NDR2 (human)
Treatment
  • cAMP_analog
  • IGF-1
  • siRNA
NuaK1 (human) QKDKFLQtFCGSPLY T211-p
NuaK1 (mouse) QKDKFLQTFCGSPLY T212
NuaK1 (rat) QKDKFLQTFCGSPLY T212
R284-m1
SDARGLIrWMLMVNP
0 1
NuaK1 (human) SDARGLIrWMLMVNP R284-m1
NuaK1 (mouse) SDARGLIRWMLMVNP R285
NuaK1 (rat) SDARGLIRWMLMVNP R285
T356-p
MKGLAKPtTSEVMLE
0 1
NuaK1 (human) MKGLAKPtTSEVMLE T356-p
NuaK1 (mouse) MKGLAKPGASEVVLE G357
NuaK1 (rat) AKMKAKPGASEVVLE G355
S367
VMLERQRSLKKSKKE
0 5
NuaK1 (human) VMLERQRSLKKSKKE S367
NuaK1 (mouse) VVLERQRsLKKSKKE S368-p
NuaK1 (rat) VVLERQRSLKKSKKE S366
S388-p
GQDAVPEsPSKLSSK
0 2
NuaK1 (human) GQDAVPEsPSKLSSK S388-p
NuaK1 (mouse) GQDSVPESPSKLSSK S389
NuaK1 (rat) GQDSLPESPSKLSSK S387
S444-p
RTGVLLPssPEAEVP
0 1
NuaK1 (human) RTGVLLPssPEAEVP S444-p
NuaK1 (mouse) RTAIPLPSsPEADMS S445
NuaK1 (rat) RTAIPLPGsPEAQGS G443
S445-p
TGVLLPssPEAEVPG
Upstream
1 6
Putative in vivo kinases:
  • CDK1 (human)
NuaK1 (human) TGVLLPssPEAEVPG S445-p
NuaK1 (mouse) TAIPLPSsPEADMSG S446-p
NuaK1 (rat) TAIPLPGsPEAQGSS S444-p
S455-p
AEVPGKLsPKQsATM
0 10
NuaK1 (human) AEVPGKLsPKQsATM S455-p
NuaK1 (mouse) ADMSGKLSLKQSATM S456
NuaK1 (rat) QGSSGKLSLKQSATM S455
S459-p
GKLsPKQsATMPKKG
0 1
NuaK1 (human) GKLsPKQsATMPKKG S459-p
NuaK1 (mouse) GKLSLKQSATMPKKG S460
NuaK1 (rat) GKLSLKQSATMPKKG S459
S476-p
KKTQQREsGYYsSPE
Upstream
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
Putative in vivo kinases:
  • PLK1 (human)
Treatment
  • BI2536
  • calyculin_A
NuaK1 (human) KKTQQREsGYYsSPE S476-p
NuaK1 (mouse) KKTQQRESGYYSSPE S477
NuaK1 (rat) KKTQQRESGYYSsPE S476
S480-p
QREsGYYsSPERSES
Upstream
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
Putative in vivo kinases:
  • PLK1 (human)
Treatment
  • BI2536
  • calyculin_A
NuaK1 (human) QREsGYYsSPERSES S480-p
NuaK1 (mouse) QRESGYYSSPERSES S481
NuaK1 (rat) QRESGYYSsPERSES S480
S481
REsGYYsSPERSESS
0 1
NuaK1 (human) REsGYYsSPERSESS S481
NuaK1 (mouse) RESGYYSSPERSESS S482
NuaK1 (rat) RESGYYSsPERSESS S481-p
S499-p
DSNDVMGsSIPSPSP
0 1
NuaK1 (human) DSNDVMGsSIPSPSP S499-p
NuaK1 (mouse) DSNDVVISGGLSSPP S500
NuaK1 (rat) DSNNVIISSGLSSPP S499
S516-p
PARVTSHsLsCRRKG
0 1
NuaK1 (human) PARVTSHsLsCRRKG S516-p
NuaK1 (mouse) PARGTSHSLSCRRKG S517
NuaK1 (rat) PARGTSHSLSCRRKG S516
S518-p
RVTSHsLsCRRKGIL
0 2
NuaK1 (human) RVTSHsLsCRRKGIL S518-p
NuaK1 (mouse) RGTSHSLSCRRKGIL S519
NuaK1 (rat) RGTSHSLSCRRKGIL S518
S562-p
GVPAEGLsRsYSRPS
0 2
NuaK1 (human) GVPAEGLsRsYSRPS S562-p
NuaK1 (mouse) GVPSDGIsRsYSRPS S563-p
NuaK1 (rat) GVPSDGISRSYSRPS S562
S564-p
PAEGLsRsYSRPSSV
0 2
NuaK1 (human) PAEGLsRsYSRPSSV S564-p
NuaK1 (mouse) PSDGIsRsYSRPSSI S565-p
NuaK1 (rat) PSDGISRSYSRPSSI S564
S600-p
PARQRIRsCVsAENF
Upstream
Downstream
4 0
Effects on Modified Protein
  • activity, induced
Effects on Biological Processes:
  • cell motility, altered
Kinase, in vitro:
  • Akt1 (human)
Putative in vivo kinases:
  • Akt1 (human)
Treatment
  • IGF-1
  • LY294002
  • U0126
NuaK1 (human) PARQRIRsCVsAENF S600-p
NuaK1 (mouse) PARQRIRSCVSAENF S601
NuaK1 (rat) PARQRIRSCVSAENF S600
S603-p
QRIRsCVsAENFLQI
0 1
NuaK1 (human) QRIRsCVsAENFLQI S603-p
NuaK1 (mouse) QRIRSCVSAENFLQL S604
NuaK1 (rat) QRIRSCVSAENFLQL S603
T641
DSSFSLLTDMDDVTQ
0 1
NuaK1 (human) DSSFSLLTDMDDVTQ T641
NuaK1 (mouse) DSSFSLLtDMDDVTQ T638-p
NuaK1 (rat) DSSFSLLADMDDVTQ A641